Oncologist Vinay Prasad, a divisive critic of COVID-19 responses, will be the next top vaccine regulator at the Food and Drug Administration, agency Commissioner Martin Makary announced on social media Tuesday .

Prasad will head the FDA's Center for Biologics Evaluation and Research (CBER), which is in charge of approving and regulating vaccines and other biologics products, such as gene therapies and blood products.

"Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward," Makary wrote on social media.

Read full article

Comments

Oncologist Vinay Prasad, a divisive critic of COVID-19 responses, will be the next top vaccine regulator at the Food and Drug Administration, agency Commissioner Martin Makary announced on social media Tuesday .

Prasad will head the FDA's Center for Biologics Evaluation and Research (CBER), which is in charge of approving and regulating vaccines and other biologics products, such as gene therapies and blood products.

"Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward," Makary wrote on social media.

Read full article

Comments

Oncologist Vinay Prasad, a divisive critic of COVID-19 responses, will be the next top vaccine regulator at the Food and Drug Administration, agency Commissioner Martin Makary announced on social media Tuesday .

Prasad will head the FDA's Center for Biologics Evaluation and Research (CBER), which is in charge of approving and regulating vaccines and other biologics products, such as gene therapies and blood products.

"Dr. Prasad brings the kind of scientific rigor, independence, and transparency we need at CBER—a significant step forward," Makary wrote on social media.

Read full article

Comments